Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity in mice

FASEB Journal

Volumn 12, Issue 10, 1998, Pages 905-912

  Muralikrishnan, D ^a   Mohanakumar, K P ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Antioxidant enzymes; Dopamine neurotoxicity; Free radical scavenger; GSH; Hydroxyl radicals; MPTP; Neuroprotection

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANTIOXIDANT; BROMOCRIPTINE; CATALASE; DOPAMINE; DOPAMINE RECEPTOR; GLUTATHIONE; HYDROXYL RADICAL; SCAVENGER; SUPEROXIDE DISMUTASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINE METABOLISM; ENZYME ACTIVITY; HYDROXYLATION; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PUTAMEN;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BEHAVIOR, ANIMAL; BROMOCRIPTINE; DOPAMINE AGENTS; DOPAMINE AGONISTS; HYDROXYL RADICAL; MICE; MICE, INBRED BALB C; MOTOR NEURONS; MOTOR SKILLS DISORDERS; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0031801548     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Burns, R. S., Chinch, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., and Kopin, I. J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546-4550
2. Heikkila, R. E., Hess, A. G., and Duvoisin, R. C. (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224, 1451-1453
3. Mitra, N., Mohanakumar, K. P., and Ganguly, D. K. (1994) Resistance of golden hamster to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Relationship with low levels of regional monoamine oxidase-B. J. Neurochem. 62, 1906-1912
4. Javitch, J. A., D'Amato, R. I., Strittmater, S. M., and Snyder, S. H. (1985) Parkinsonism-inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenyl pyridinium by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82, 2173-2177
5. Tipton, K. F., and Singer, T. P. (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61, 1191-1206
6. Chiueh, C. C., Wu, R. M., Mohanakumar, K. P., Sternberger, L. M., Krishna, G., Obata, T., and Murphy, D. L. (1994) In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann. N.Y. Acad. Sci. 738, 25-36
7. Mohanakumar, K. P., de Bartolomeis, A., Wu, R. M., Yeh, K. J., Sternberger, L. M., Peng, S. Y., Murphy, D. L., and Chiueh, C. C. (1994) Ferrous citrate complex and nigral degeneration: evidence for free radical formation and lipid peroxidation. Ann. N. Y. Acad. Sci. 738, 392-399
8. Cohen, G., and Heikkila, R. E. (1974) The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialoric acid and related cytotoxic agents. J. Biol. Chem. 249, 2447-2452
9. Braughler, J. M., and Hall, E. D. (1989) Central nervous system trauma and stroke. 1. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radical Biol. Med. 6, 289-301
10. Clemens, J. A., and Panetta, J. A. (1994) Neuroprotection by antioxidants in models of global and focal ischemia. Ann. N.Y. Acad. Sci. 738, 250-256
11. Mohanakumar, K. P., de Bartolomeis, A., Wu, R. M., Yeh, K. J., Sternberger, L. M., Peng, A., Murphy, D. L., and Chiueh, C. C. (1994) Effect of low mass iron complex on free radical formation, lipid peroxidation and nigral injury. New Trends Clin. Neuropharmacol. 8, 50
12. + toxicity by deprenyl (selegeline). Ann. N.Y. Acad. Sci. 738, 214-221
13. Acuna-Castroviejo, D., Cotomontes, A., Monti, G. G., Ortis, G. G., and Reiter, R. J. (1997) Melatonin is protective against MPTP-induced striatal and hipppcampal lesions. Life Sci. 60, 2329
14. Calne, D. B., Teychenne, P. F., Claveria, L. E., Eastman, R., Greenacre, J. K., and Petne, A. (1974) Broniocriptine in parkinsonism. Br. Med. J. 4, 442-444
15. Yoshikawa, T., Minamiyama, Y., Naito, Y., and Kondo, M. (1994) Antioxidant properties of bromocriptine, a dopamine agonist. J. Neurochem. 62, 1034-1038
16. Ogawu, N., Tanaka, K., Asanuma, M., Kawai, M., Masumizu, T., Kohno, M., and Mori, A. (1994) Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro. Brain Res. 657, 207-213
17. Kondo, T., Ito, T., and Sugita, Y. (1094) Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depiction in mouse sirialiun. Ann. N.Y. Acad. Sci. 738, 222-229
18. Aral, N., Isaji, M., Miyata, H., Fukuyama, J., Minuta, E., and Kuno, S. (1995) Differential effects of three dopamine receptor agonists in MPTP-treated monkeys. J. Neural Transm. 10, 55-62
19. Gagnon, C., Bedard, P. J., and Di Paolo, T. (1990) Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/ or D-2 receptor agonists. Eur. J. Pharmacol 178, 115-120
20. 2 agonist on spontaneous motor activity in MPTP treated mice. Pharmacol. Toxicol. 75, 36-41
21. Mitra, N., Mohanakumar, K. P., and Ganguly, D. K. (1992) Dissociation of serotoninergic and dopaminergic components in acute effects of 1-meuiyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.Brain Res. Bull.28, 355-364
22. Weimuller, F. B., Hadjiconstantinou, M., and Bruno, J. P. (1988) Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice. Neurosci. Lett. 85, 137-142
23. Mohanakumar, K. P., Mitra, N., and Ganguly, D. K. (1990) Tremorogenesis by physostigmine is unrelated to acetylcholinesterase inhibition: evidence for serotoninergic involvement. Neurosci. Lett. 120, 91-93
24. Halliwell, B., Kaur, H., and Ingelman-Sundberg, M. (1991) Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Radical Biol. Med. 10, 439-441
25. Marklund, S., and Markhmd, G. (1974) Involvement of superoxide anion radical in die autoxichuion of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469-474
26. Aebi, H. (1984) Catalase in vitro. Methods Enzymol. 105, 121-126
27. Cohn, V. H., and Lyle, J. (1966) A fluorimetric assay for glutathione. Anal. Biochcm. 14, 434-440
28. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
29. Felten, D. L., Feiten, S. Y., Fuller, R. W., Romano, T. D., Smalstig, E. B., Wong, D. T., and Clemens, J. A. (1992) Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fisher-344 rats. Neurobiol. Aging 13, 339-351
30. Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., and Marsden, C. D. (1987) Increased nigral iron content in postmortem parkin son ian brain. Lancet ii, 1219-1220
31. Dexter, D., Carter, C., Agid, F., Agid, Y., Lees, A. J., Jenner, P., and Marsden, C. D. (1986) Lipid peroxidation as cause of nigral cell death in Parkinson's disease. Lancet ii, 639-640
32. Perry, T. L., Godin, D. V., and Hansen, S. (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33, 305-310
33. Kish, S. J., Morito, C., and Hornykiewicz, O. (1985) Glutathione peroxidase activity in Parkinson's disease brain. Neurosci. Lett. 58, 343-346
34. Ambani, L. M., Van Woert, M. H., and Murphy, S. (1975) Bruin peroxidase and catalase in Parkinson's disease. Arch. Neurol. 32, 114-118
35. Temlett, J. A. Landsberg, P., Watt, F., and Grime, G. W. (1994) Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian green monkey: evidence from proton microprobe elemental microanalysis. J. Neurochem. 62, 134-146
36. Mochizuki, H., Imai, H., Eudo, K., Yokomizo, K., Murata, Y., Hattori, N., and Mizuno, Y. (1994) Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) -induced hemiparkinsonian monkeys. Neurosci. Lett. 168, 251-253
37. Nakamuni, H., Kato, S., and Tanaka, J. (1989) Mitochondria covered with a net of parallel and latticed filaments in nigral neurons of monkeys with experimental parkinsonism. Acta Neuropathol 77, 489-493
38. Mizuno, Y., Suzuki, K., Sone, N., and Saitoh, T. (1988) Inhibition of mitochondrial respiration by 1-methyl-4-pheriyl-1,2,3;6-tetrahydropyridine in mouse brain in vivo. Neurosci. Lett. 91, 349-353
39. +. J. Neural Transm. 89, 139-145
40. Sziraki, I., Mohanakumar, K. P., Rauhala, P., Kim, H. G., Yeh, K. J., and Chiueh, C. C. (1998) Manganese: a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism. Neuroscience In press
41. Chiba, K., Trevor, A., and Castagnoli, N., Jr. (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. to. Commun. 120, 574-578
42. Zang, L. Y., and Misra, H. P. (1993) Generation of reactive oxygen species during the monoainine oxidase-catalyzed oxidation of the neurotoxicam 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Biol. Chem. 268, 16504-16512
43. +-induced oxygen radical formation with mitochondrial enzymes. Free Radical Biol. Med. 15, 181-186
44. Thifiault, C., Aumont, N., Quirion, R., and Poirier, J. (1905) Effects of MPTP and Ixleprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain. J. Neurochem. 65, 2725-2733
45. +) levels, ascorbic acid oxidation and glutathionc levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated rat. Neurosci. Lett. 161, 121-123
46. Oishi, T., Hasegawa, E., and Murai, T. (1993) Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-toirahydopyridine (MPTP) in the mouse. J. Neural Transm. Parkinson's Dis. Dementia Sect. 6, 45-52
47. Marzatico, F., Café, C., Taborelli, M., and Benzi, G. (1993) Experimental Parkinson's disease in monkeys: effect of ergot alkaloid derivative on lipid peroxidation in different brain areas. Neurochem. Res. 18, 1101-1116
48. + toxicity in nigral dopaminergic neurones. Neuroreport 7, 921-923
49. Burki, H. R. (1978) Lack of effect of bromocriptine on the activity of monoamine oxidase in rat brain. J. Pharm. Pharmacol. 30, 261-262
50. Jackson, D. M., Jenkins, O. F., and Ross, S. B. (1988) The motor effects of bromocriptine - a review. Psychopharmacology 95, 433-446
51. Przedborski, S., Jackson-Lewis, V., and Falin, S. (1995) Antipar-kinsonian therapies and brain mitochondrial complex I activity. Movement Disorders 10, 312-317